Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|April 19, 2000
Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitorsS Rusconi, S La Seta Catamancio, P Citterio, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2000
Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluidG Tambussi, A Gori, B Capiluppi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1987
Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude miceA Benomar, W J Ming, G Taraboletti, et al.
Clinical Immunology and Immunopathology|January 1, 1989
Clinical and immunological aspects of HIV infection in drug addictsM Galli, A Lazzarin, A Saracco, et al.
AIDS Research and Human Retroviruses|September 1, 1996
Virologic and immunologic markers of disease progression in pediatric HIV infectionA Viganò, C Balotta, D Trabattoni, et al.
AIDS Research and Human Retroviruses|July 20, 1996
Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infectionM Clerici, C Balotta, L Meroni, et al.
AIDS (London, England)|July 14, 2000
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategyS Menzo, S Rusconi, A Monachetti, et al.
Journal of Biological Regulators and Homeostatic Agents|November 6, 2001
Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individualsR Mazzucchelli, S Corvasce, M Violin, et al.
Antiviral Therapy|December 1, 1996
Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected peopleS Rusconi, M P De Pasquale, F Mainini, et al.
Blood|July 15, 1996
Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infectionM Clerici, C Balotta, A Salvaggio, et al.
Pageof 4